Loading GSK charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading GSK comparable companies…
| GSKGSK plc(opens in a new tab) | $101.94B | $43.09B | +7.5% | 72.4% | 24.3% | 2.37× | 13.5× |
|---|---|---|---|---|---|---|---|
| ABTAbbott Laboratories(opens in a new tab) | $185.17B | $46.59B | +8.1% | 56.6% | 15.8% | 3.97× | 34.3× |
| NVONovo Nordisk A S(opens in a new tab) | — | $46.82B | +11.1% | 81.0% | 41.3% | — | — |
| BMYBristol Myers Squibb Co.(opens in a new tab) | $128.25B | $50.03B | +4.2% | 69.2% | — | 2.56× | 13.9× |
| AZNAstrazeneca plc(opens in a new tab) | — | $58.74B | +8.6% | 81.9% | 23.4% | — | — |
| Medianpeers, excl. GSK | $156.71B | $48.43B | +8.3% | 75.1% | 23.4% | 3.27× | 24.1× |